March 28, 2012Cancer Epidemiology Biomarkers & PreventionOpen Access

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

View Full Paper

Ask AI

Bookmark

Abstract

These findings can lead to an improved understanding of tumor development and may prove useful for breast and ovarian cancer risk prediction for BRCA1 and BRCA2 mutation carriers.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Couch et al. (2012) studied this question.

synapsesocial.com/papers/69dc8b4a89c4deb67d35914f https://doi.org/10.1158/1055-9965.epi-11-0888

View Full Paper

Ask AI

Bookmark

Abstract

These findings can lead to an improved understanding of tumor development and may prove useful for breast and ovarian cancer risk prediction for BRCA1 and BRCA2 mutation carriers.

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Abstract

Discussion

Cite This Study

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Abstract

Discussion

Cite This Study

Also Consider

Also Consider